by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals with AML and MDS. Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals with AML and...
by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
A seven-year-old boy dies from organ failure after chemotherapy is used in an experimental treatment. A seven-year-old boy dies from organ failure after chemotherapy is used in an experimental treatment.
by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
The Global Clinical Trials Market reached USD 56 640 7 million in 2022 and is projected to witness lucrative growth by reaching up to USD 99 212 0 million by 2031 The clinical trials market is expected to exhibit a … The Global Clinical Trials Market reached...
by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic cancer respond to immunotherapies. Researchers have discovered race-associated molecular differences in tumors that may impact the way...
by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
Li-Yuan Bai, M.D., M.M.S., Ph.D. Li-Yuan Bai, M.D., M.M.S., Ph.D.
